Sysmex

Sysmex Liabilities

The The Liabilities of Sysmex (6869.T) as of Oct 9, 2026 is 201.85 B JPY. In the previous year, The Liabilities was 200.73 B JPY — a change of 0.56% (higher).

Liabilities

201.85 BJPY

YoY

0.56%

Last updated:

In 2026, Sysmex's total liabilities amounted to 201.85 B JPY, a 0.56% difference from the 200.73 B JPY total liabilities in the previous year.

The Sysmex Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2019
81.59 B JPY
Jan 1, 2020
110.94 B JPY
Jan 1, 2021
118.81 B JPY
Jan 1, 2022
134.65 B JPY
Jan 1, 2023
142.72 B JPY
Jan 1, 2024
186.02 B JPY
Jan 1, 2025
200.73 B JPY
Jan 1, 2026
201.85 B JPY
The Sysmex Liabilities history
YEARLiabilitiesYoY
201.85 BJPY+0.56%
200.73 BJPY+7.91%
186.02 BJPY+30.34%
142.72 BJPY+5.99%
134.65 BJPY+13.34%
118.81 BJPY+7.09%
110.94 BJPY+35.98%
81.59 BJPY+1.31%
80.53 BJPY+15.76%
69.57 BJPY-16.05%
82.86 BJPY+5.65%
78.43 BJPY+21.59%
64.51 BJPY—
Access this data via the Eulerpool API

Sysmex Stock analysis

What does Sysmex do? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing Sysmex's Liabilities

Sysmex's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Sysmex's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Sysmex's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Sysmex's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Sysmex’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Sysmex stock

The Liabilities of Sysmex is 201.85 B JPY in 2026.

The Liabilities of Sysmex changed from 200.73 B JPY to 201.85 B JPY, representing a 0.56% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities Sysmex since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's Sysmex historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Sysmex

All Key Metrics — Sysmex